This article comprises a summary of scientific sessions on β-thalassaemia that took place on 2nd–4th February 2017, as part of the European Hematology Association Scientific Working Group meeting: Anaemias: Diagnosis and Treatment in the Omics Era, in Barcelona, Spain
In this issue
Rate this content's potential impact on patient outcomes
Average rating / 5. Vote count:
No votes so far! Be the first to rate this content.